Showing results (91-100 of 136) with videos related to
Sort By:
Pageof 14
The Journal of Antibiotics|June 2, 2025
New oligomycin derivatives inhibit anchorage-independent growth of pancreatic cancer cellsDaisuke Tatsuda, Masahide Amemiya, Chisato Nosaka, et al.Oncology Reports|July 20, 2022
Defucosylated mouse‑dog chimeric anti‑HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumorsHiroyuki Suzuki, Tomokazu Ohishi, Teizo Asano, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 15, 2019
Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-41 Exerts Antitumor Activity in a Mouse Xenograft Model of Colon CancerYukinari Kato, Tomokazu Ohishi, Shinji Yamada, et al.International Journal of Molecular Sciences|September 14, 2024
Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell CarcinomasKenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 20, 2020
An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H2Mab-19 Exerts Antitumor Activity in Mouse Colon Cancer XenograftsYukinari Kato, Tomokazu Ohishi, Junko Takei, et al.Pharmaceutics|November 26, 2022
Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine OsteosarcomaNami Tateyama, Hiroyuki Suzuki, Tomokazu Ohishi, et al.Journal of Proteome Research|December 17, 2023
NDUFA12 as a Functional Target of the Anticancer Compound Ertredin in Human Hepatoma Cells As Revealed by Label-Free Chemical ProteomicsSe In Park, Sung Min Cho, Sonoko Atsumi, et al.Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|November 16, 2022
Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf)Hiroyuki Suzuki, Teizo Asano, Tomokazu Ohishi, et al.International Journal of Cancer|March 8, 2020
Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cellsTomokazu Ohishi, Hikaru Abe, Chiharu Sakashita, et al.Bioorganic & Medicinal Chemistry|May 12, 2012
Cleavage mechanism and anti-tumor activity of 3,6-epidioxy-1,10-bisaboladiene isolated from edible wild plantsKen-ichi Kimura, Yoshimi Sakamoto, Nozomi Fujisawa, et al.Pageof 14